ECMO Patients' hidden infection risk under the microscope

NCT ID NCT05566665

Ongoing Knowledge-focused Sponsor: Policlinico Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 200 adults on ECMO (a heart-lung machine) for severe breathing problems. Researchers track how many get hospital-acquired infections and measure antibiotic levels in their blood and lungs. The goal is to learn more about infections and drug dosing in these critically ill patients, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors choose the right antibiotic doses for ECMO patients, potentially reducing infection-related deaths.
What could go wrong: This is an observational study, not a treatment trial. It only collects data, so it cannot directly improve patient outcomes. Results may not apply to all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome adult acute respiratory distress syndrome nosocomial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RESPIRATORY DISTRESS SYNDROME EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION NOSOCOMIAL INFECTION

Contacts and locations

Locations

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico

Milan, MI, 20122, Italy
Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico

Milan, Milan, 20100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.